Latest News and Press Releases

Hops Scalable Vision Jet Fleet Expansion Unlocking High-Frequency Short-Haul Regional Travel Flyte’s Vision Jet-Powered Hops Platform Aims to Establish a New Standard in Regional Travel with...

LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately 460 patients Primary endpoint to evaluate change in PANSS total score at...

BRISTOL, Tenn., March 25, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) is drawing increased attention following its expansion into the $16.3 billion glaucoma market through a...

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company...

- Reports Revenue of $5.6 Million – Posting fourth consecutive quarter of growth and highest recorded annual revenue in the Company’s history -- Lowest Quarterly Net Loss since 2013 – Evidencing...

Kenmare Resources plc (“Kenmare” or the “Company” or the “Group”) 25 March 2026 2025 PRELIMINARY RESULTS Kenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of titanium...

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of FMC Corporation (“FMC” or the “Company”) (NYSE: FMC).  Such investors are advised to...

Fourth quarter and full year results reflect temporary planned scale back in wholesale production At year-end was back to fully planted with legacy greenhouses and the most overall acreage planted in...

Completed randomization in REMAIN-1 Pivotal Cohort; topline 6-Month data expected in early Q4 2026 Received favorable FDA feedback on De Novo classification request; De Novo submission expected in...

New York City, NY, March 24, 2026 (GLOBE NEWSWIRE) -- Gelatide is the subject of a newly released 2026 informational consumer evaluation detailing the marketing claims, ingredient research context,...